Cargando…

Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagnosis and High Resection Rate

SIMPLE SUMMARY: Patients with pancreatic cancer are often diagnosed at an advanced stage. However, the incidental detection of pancreatic duct dilatation during surveillance for hepatocellular carcinoma often leads to the early diagnosis of pancreatic cancer in patients with viral hepatitis-related...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumagi, Teru, Terao, Takashi, Kuroda, Taira, Koizumi, Mitsuhito, Imamura, Yoshiki, Ohno, Yoshinori, Yokota, Tomoyuki, Azemoto, Nobuaki, Uesugi, Kazuhiro, Kisaka, Yoshiyasu, Tanaka, Yoshinori, Shibata, Naozumi, Miyata, Hideki, Miyake, Teruki, Hiasa, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913713/
https://www.ncbi.nlm.nih.gov/pubmed/36765521
http://dx.doi.org/10.3390/cancers15030561
_version_ 1784885493710716928
author Kumagi, Teru
Terao, Takashi
Kuroda, Taira
Koizumi, Mitsuhito
Imamura, Yoshiki
Ohno, Yoshinori
Yokota, Tomoyuki
Azemoto, Nobuaki
Uesugi, Kazuhiro
Kisaka, Yoshiyasu
Tanaka, Yoshinori
Shibata, Naozumi
Miyata, Hideki
Miyake, Teruki
Hiasa, Yoichi
author_facet Kumagi, Teru
Terao, Takashi
Kuroda, Taira
Koizumi, Mitsuhito
Imamura, Yoshiki
Ohno, Yoshinori
Yokota, Tomoyuki
Azemoto, Nobuaki
Uesugi, Kazuhiro
Kisaka, Yoshiyasu
Tanaka, Yoshinori
Shibata, Naozumi
Miyata, Hideki
Miyake, Teruki
Hiasa, Yoichi
author_sort Kumagi, Teru
collection PubMed
description SIMPLE SUMMARY: Patients with pancreatic cancer are often diagnosed at an advanced stage. However, the incidental detection of pancreatic duct dilatation during surveillance for hepatocellular carcinoma often leads to the early diagnosis of pancreatic cancer in patients with viral hepatitis-related chronic liver disease. While pancreatic cancer can be diagnosed early, patients may have advanced chronic liver disease that precludes surgical resection, and the long-term prognosis is unknown for these patients. This study aimed to determine the long-term prognosis of pancreatic cancer patients with viral hepatitis-related chronic liver disease. We found that patients with viral hepatitis-related chronic liver disease under surveillance for hepatocellular carcinoma have a favorable long-term outcome for pancreatic cancer due to earlier diagnosis at earlier stages when resection is more feasible. ABSTRACT: Patients with viral hepatitis-related chronic liver disease (CLD) under surveillance for hepatocellular carcinoma (HCC) are often diagnosed with pancreatic cancer (PC) at an early stage. However, the long-term outcomes of these patients are unclear. We aimed to clarify the long-term outcomes of patients with PC with viral hepatitis-related CLD using a chart review. Data collection included the Union for International Cancer Control (UICC) stage at PC diagnosis, hepatitis B virus and hepatitis C virus status, and long-term outcomes. The distribution of the entire cohort (N = 552) was as follows: early stage (UICC 0-IB; n = 52, 9.5%) and non-early stages (UICC IIA-IV; n = 500, 90.5%). At diagnosis, the HCC surveillance group (n = 18) had more patients in the early stages than the non-surveillance group (n = 534) (50% vs. 8.0%), leading to a higher indication rate for surgical resection (72.2% vs. 29.8%) and a longer median survival time (19.0 months vs. 9.9 months). We confirmed that patients with viral hepatitis-related CLD under HCC surveillance were diagnosed with PC at an early stage. Because of the higher indication rate for surgical resection in these patients, they had favorable long-term outcomes for PC.
format Online
Article
Text
id pubmed-9913713
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99137132023-02-11 Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagnosis and High Resection Rate Kumagi, Teru Terao, Takashi Kuroda, Taira Koizumi, Mitsuhito Imamura, Yoshiki Ohno, Yoshinori Yokota, Tomoyuki Azemoto, Nobuaki Uesugi, Kazuhiro Kisaka, Yoshiyasu Tanaka, Yoshinori Shibata, Naozumi Miyata, Hideki Miyake, Teruki Hiasa, Yoichi Cancers (Basel) Article SIMPLE SUMMARY: Patients with pancreatic cancer are often diagnosed at an advanced stage. However, the incidental detection of pancreatic duct dilatation during surveillance for hepatocellular carcinoma often leads to the early diagnosis of pancreatic cancer in patients with viral hepatitis-related chronic liver disease. While pancreatic cancer can be diagnosed early, patients may have advanced chronic liver disease that precludes surgical resection, and the long-term prognosis is unknown for these patients. This study aimed to determine the long-term prognosis of pancreatic cancer patients with viral hepatitis-related chronic liver disease. We found that patients with viral hepatitis-related chronic liver disease under surveillance for hepatocellular carcinoma have a favorable long-term outcome for pancreatic cancer due to earlier diagnosis at earlier stages when resection is more feasible. ABSTRACT: Patients with viral hepatitis-related chronic liver disease (CLD) under surveillance for hepatocellular carcinoma (HCC) are often diagnosed with pancreatic cancer (PC) at an early stage. However, the long-term outcomes of these patients are unclear. We aimed to clarify the long-term outcomes of patients with PC with viral hepatitis-related CLD using a chart review. Data collection included the Union for International Cancer Control (UICC) stage at PC diagnosis, hepatitis B virus and hepatitis C virus status, and long-term outcomes. The distribution of the entire cohort (N = 552) was as follows: early stage (UICC 0-IB; n = 52, 9.5%) and non-early stages (UICC IIA-IV; n = 500, 90.5%). At diagnosis, the HCC surveillance group (n = 18) had more patients in the early stages than the non-surveillance group (n = 534) (50% vs. 8.0%), leading to a higher indication rate for surgical resection (72.2% vs. 29.8%) and a longer median survival time (19.0 months vs. 9.9 months). We confirmed that patients with viral hepatitis-related CLD under HCC surveillance were diagnosed with PC at an early stage. Because of the higher indication rate for surgical resection in these patients, they had favorable long-term outcomes for PC. MDPI 2023-01-17 /pmc/articles/PMC9913713/ /pubmed/36765521 http://dx.doi.org/10.3390/cancers15030561 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kumagi, Teru
Terao, Takashi
Kuroda, Taira
Koizumi, Mitsuhito
Imamura, Yoshiki
Ohno, Yoshinori
Yokota, Tomoyuki
Azemoto, Nobuaki
Uesugi, Kazuhiro
Kisaka, Yoshiyasu
Tanaka, Yoshinori
Shibata, Naozumi
Miyata, Hideki
Miyake, Teruki
Hiasa, Yoichi
Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagnosis and High Resection Rate
title Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagnosis and High Resection Rate
title_full Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagnosis and High Resection Rate
title_fullStr Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagnosis and High Resection Rate
title_full_unstemmed Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagnosis and High Resection Rate
title_short Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagnosis and High Resection Rate
title_sort patients with chronic liver disease under surveillance for hepatocellular carcinoma have a favorable long-term outcome for pancreatic cancer due to early diagnosis and high resection rate
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913713/
https://www.ncbi.nlm.nih.gov/pubmed/36765521
http://dx.doi.org/10.3390/cancers15030561
work_keys_str_mv AT kumagiteru patientswithchronicliverdiseaseundersurveillanceforhepatocellularcarcinomahaveafavorablelongtermoutcomeforpancreaticcancerduetoearlydiagnosisandhighresectionrate
AT teraotakashi patientswithchronicliverdiseaseundersurveillanceforhepatocellularcarcinomahaveafavorablelongtermoutcomeforpancreaticcancerduetoearlydiagnosisandhighresectionrate
AT kurodataira patientswithchronicliverdiseaseundersurveillanceforhepatocellularcarcinomahaveafavorablelongtermoutcomeforpancreaticcancerduetoearlydiagnosisandhighresectionrate
AT koizumimitsuhito patientswithchronicliverdiseaseundersurveillanceforhepatocellularcarcinomahaveafavorablelongtermoutcomeforpancreaticcancerduetoearlydiagnosisandhighresectionrate
AT imamurayoshiki patientswithchronicliverdiseaseundersurveillanceforhepatocellularcarcinomahaveafavorablelongtermoutcomeforpancreaticcancerduetoearlydiagnosisandhighresectionrate
AT ohnoyoshinori patientswithchronicliverdiseaseundersurveillanceforhepatocellularcarcinomahaveafavorablelongtermoutcomeforpancreaticcancerduetoearlydiagnosisandhighresectionrate
AT yokotatomoyuki patientswithchronicliverdiseaseundersurveillanceforhepatocellularcarcinomahaveafavorablelongtermoutcomeforpancreaticcancerduetoearlydiagnosisandhighresectionrate
AT azemotonobuaki patientswithchronicliverdiseaseundersurveillanceforhepatocellularcarcinomahaveafavorablelongtermoutcomeforpancreaticcancerduetoearlydiagnosisandhighresectionrate
AT uesugikazuhiro patientswithchronicliverdiseaseundersurveillanceforhepatocellularcarcinomahaveafavorablelongtermoutcomeforpancreaticcancerduetoearlydiagnosisandhighresectionrate
AT kisakayoshiyasu patientswithchronicliverdiseaseundersurveillanceforhepatocellularcarcinomahaveafavorablelongtermoutcomeforpancreaticcancerduetoearlydiagnosisandhighresectionrate
AT tanakayoshinori patientswithchronicliverdiseaseundersurveillanceforhepatocellularcarcinomahaveafavorablelongtermoutcomeforpancreaticcancerduetoearlydiagnosisandhighresectionrate
AT shibatanaozumi patientswithchronicliverdiseaseundersurveillanceforhepatocellularcarcinomahaveafavorablelongtermoutcomeforpancreaticcancerduetoearlydiagnosisandhighresectionrate
AT miyatahideki patientswithchronicliverdiseaseundersurveillanceforhepatocellularcarcinomahaveafavorablelongtermoutcomeforpancreaticcancerduetoearlydiagnosisandhighresectionrate
AT miyaketeruki patientswithchronicliverdiseaseundersurveillanceforhepatocellularcarcinomahaveafavorablelongtermoutcomeforpancreaticcancerduetoearlydiagnosisandhighresectionrate
AT hiasayoichi patientswithchronicliverdiseaseundersurveillanceforhepatocellularcarcinomahaveafavorablelongtermoutcomeforpancreaticcancerduetoearlydiagnosisandhighresectionrate